Reference · compound index
Most of this index is still blank.
It is a record of the compounds we list — what each one is, its physical properties, and the published human trials, linked to the papers rather than to our summary of them.
Almost none of that is filled in yet. Each field is sourced one at a time from the primary record, and a field we have not sourced stays visibly empty instead of being filled with something plausible. We publish it in that state because a blank line is itself information: it tells you exactly how much of what you are reading has been checked.
Nothing here is advice. There are no doses on these pages and no protocols. Where a study appears it is described as something researchers did, with a link to the paper.
The record
17 entries · 0 with a documented record
AOD-9604
Stub entry
Modified fragment of human growth hormone, residues 176-191. Not somatropin and not a growth hormone.
BPC-157
Stub entry
Pentadecapeptide derived from a gastric protein. Almost all published work is preclinical.
CJC-1295
Stub entry
GHRH analog, also called modified GRF(1-29). Short half-life relative to the DAC form.
Epitalon
Stub entry
Synthetic tetrapeptide. Human data is limited and largely from a single research group.
GHK-Cu
Stub entry
Copper tripeptide complex. The most studied compound here for topical/cosmetic research.
Hexarelin
Stub entry
Synthetic hexapeptide growth hormone secretagogue.
Ipamorelin
Stub entry
Selective growth hormone secretagogue receptor agonist.
KPV
Stub entry
Tripeptide fragment of alpha-MSH.
MOTS-c
Stub entry
Mitochondrial-derived peptide.
NAD+
Stub entry
Nicotinamide adenine dinucleotide.
PT-141
Stub entry
Melanocortin receptor agonist.
Selank
Stub entry
Synthetic analog of tuftsin.
Semax
Stub entry
ACTH(4-10) analog.
Sermorelin
Stub entry
GHRH(1-29) fragment.
TB-500
Stub entry
Synthetic fragment of thymosin beta-4.
Tesamorelin
Stub entry
GHRH analog. The only compound in this catalog with an approved human indication elsewhere.
Thymosin alpha-1
Stub entry
Immunomodulatory peptide with an approved indication in some countries.
Reference
Published protocols
The same literature organized by trial rather than by compound: what a study administered, to whom, for how long, quoted from the source.
Catalog
What we stock
An index entry describes a compound. A catalog listing describes a specific lot of material and the paperwork that exists for it.
This index describes published literature and physical properties. It is not medical advice, not a protocol, and not a recommendation to use any compound listed here.